Dr E. Graeub AG and NoBACZ Healthcare Announce Distribution Partnership in Switzerland & Liechtenstein
Dr E. Graeub AG, a long-stranding and notable name in animal health sector, and NoBACZ Healthcare, an innovator in wound management solutions, are delighted to announce a strategic partnership. Dr E. Graeub AG will now be the exclusive distributor of NoBACZ’s livestock and equine products bringing them to Switzerland and Liechtenstein.
NoBACZ’s cutting-edge products are developed using their unique patented mineral-polymer-technology combining a natural polymer and mineral salts. They are topically applied gels or liquids that set rapidly upon application, providing a waterproof barrier: keeping environmental pathogens and contaminants out while providing a protected environment for the lesion. This innovative and patented technology, originating from the University of Cambridge, offers a versatile formulation approach to meet various needs. NoBACZ’s robust, adhesive ‘second skin’ barriers repel mud, water, detritus, and bacteria. They are intuitive and user-friendly; they self-degrade over time and are environmentally friendly.
UMBIREZ™ and AMBUGREEN™ redefine protection by providing traditional cleansing with a lasting environmental barrier. Antibiotic-free, consisting of food-and-feed grade materials, combined with essential metal ions, in a surgical spirit base UMBIREZ™ and AMBUGREEN™ have widespread application. UMBIREZ™ as a proven superior alternative to iodine for the navels of neonatal livestock, ears and ear tags and AMBUGREEN™ for a variety of uses in all species, including hooves, udders and disbudding sites. They offer long-lasting protection and are designed to be tough enough to withstand farm conditions.
Dr E. Graeub AG boasts exclusive distribution agreements with key global manufacturers and a unique range of its own brands. Their teams are uniquely positioned to provide added value to customers by helping them address and overcome their challenges with technical, business, and customer service expertise.
Together, Dr E. Graeub AG and NoBACZ are poised to bring these revolutionary animal healthcare solutions to the Swiss market, reducing antimicrobial use and ensuring enhanced animal health and welfare through superior technology.
David Charles, International Business Development Manager at NoBACZ said: “We are delighted to enter into this multi-year partnership with Dr E. Graeub AG, allowing the NoBACZ Healthcare portfolio to be supplied into Switzerland and Liechtenstein – countries renowned for their high standards and quality of care. Our goal working with Dr E. Graeub AG is to provide innovative new products into the animal health market alongside local experience and knowledge, supporting farmers and vets to improve animal health and welfare, alongside reducing antibiotic use.”
Sonja Ewerling , Product Manager Livestock at Dr. E. Graeub AG said: “ We are equally delighted for the future collaboration with this young, innovative company whose products are set to bring real value to animal health in Switzerland. Together, we look forward to shaping a healthier future for animals, advancing the industry with fresh ideas and dedication, while also embracing the welcomed reduction of antibiotics in animal care.”
For more information, please contact:
Dr. E. Graeub AG:
E: sonja.ewerling@graeub.com
NoBACZ:
E: d.charles@nobacz.com
This partnership signals a significant step forward in providing innovative and reliable healthcare solutions to the Swiss & Liechtenstein animal health sectors.
